From Casetext: Smarter Legal Research

GE Medical Systems v. Ziarati

United States Court of Appeals, Ninth Circuit
Jul 9, 2002
44 F. App'x 90 (9th Cir. 2002)

Opinion


44 Fed.Appx. 90 (9th Cir. 2002) GE MEDICAL SYSTEMS, a division of General Electric Company, a New York corporation, Plaintiff-counter-defendant--Appellee, v. Mokhtar ZIARATI, an individual, Defendant-Appellant, Resonance Technology Inc., a California corporation, Defendant-counter-claimant--Appellant. No. 01-57214. D.C. No. CV-98-03434-MRP. United States Court of Appeals, Ninth Circuit. July 9, 2002

NOT FOR PUBLICATION. (See Federal Rule of Appellate Procedure Rule 36-3) [Copyrighted Material Omitted]

Appeal from the United States District Court for the Central District of California, Mariana R. Pfaelzer, District Judge, Presiding.

Before KOZINSKI and FERNANDEZ, Circuit Judges, and KING, District Judge.

The Honorable Samuel P. King, Senior United States District Judge for the District of Hawaii, sitting by designation.

MEMORANDUM

This disposition is not appropriate for publication and may not be cited to or by the courts of this circuit except as provided by Ninth Circuit Rule 36-3.

Mokhtar Ziarati and Resonance Technology, Inc., appeal the district court's grant of summary judgment in favor of General Electric Company on its declaratory relief action to enforce an agreement regarding inventions made by Ziarati. We affirm in part, reverse in part, and remand.

(1) Ziarati and RTI first assert that the district court erred when it granted summary judgment against them on their statute of limitations defense. We agree. GE admits for purposes of summary judgment that in 1989 it knew that Ziarati had failed to assign the inventions to it and was exploiting them himself, which violated the Innovation Agreement. GE did not bring this action until 1998. Clearly, that was beyond the California four-year statute of limitations for a breach of a written contract. See Cal.Civ.Proc.Code § 337(1); Cochran v. Cochran, 56 Cal.App.4th 1115, 1120, 66 Cal.Rptr.2d 337, 340 (1997). Moreover, GE did not even make a demand for an assignment within the time provided by the statute of limitations. See Bass v. Hueter, 205 Cal. 284, 287, 270 P. 958, 959 (1928); Ginther v. Tilton, 206 Cal.App.2d 284, 285-86, 23 Cal.Rptr. 601, 602 (1962); Ilse v. Burgess, 28 Cal.App.2d 654, 657, 83 P.2d 527, 528-29 (1938); Tisdale v. Bryant, 38 Cal.App. 750, 757, 177 P. 510, 513 (1918). Nor does it

We note that on two occasions the district court has permitted GE to stipulate to certain facts for the purpose of a summary judgment motion only. That has now resulted in two appeals to this court, with concomitant delays, expense, inefficiency, and violation of judicial economy principles. The district court should look on further stipulations of that ilk with a jaded eye.

It undisputed that California law applies to this contract action. See Wade v. Lawder, 165 U.S. 624, 627, 17 S.Ct. 425, 427, 41 L.Ed. 851 (1897).

Page 92.

help GE to assert that it could not demand the assignment of the patents until they issued because it is pellucid, as GE once stipulated, that the Innovation Agreement did not separately require Ziarati to assign patents; it required him to assign the inventions themselves. A patent is just one way of protecting the right to exclusive use of an invention. See. e.g., Andrew Beckerman-Rodau, The Choice Between Patent Protection and Trade Secret Protection: A Legal and Business Decision, 84 J. Pat. & Trademark Off. Soc'y 371, 377 (2002). If GE lost the power to require assignment of the inventions, its ancillary right to Ziarati's aid in garnering patent protection for those inventions was also lost.

See Gen. Elec. Corp. v. Ziarati, No. 99-56317, 5 Fed.Appx. 664 (9th Cir.2001) (unpublished disposition).

(2) Ziarati and RTI also claim that the district court erred when it granted summary judgment against them on their laches defense. Again, we agree because the evidence would support a finding that GE inexcusably delayed making a claim against Ziarati and he was severely prejudiced. See Jarrow Formulas, Inc. v. Nutrition Now, Inc., No. 01-55154, slip op. 7995, 8005 (9 th Cir. June 4, 2002); Danjaq LLC v. Sony Corp., 263 F.3d 942, 954-55 (9th Cir.2001); Piscioneri v. City of Ontario, 95 Cal.App.4th 1037, 1049-50, 116 Cal.Rptr.2d 38, 47 (2002). Similarly, GE's knowledge and long delay, along with Ziarati's change of position in reliance thereon, might well establish an estoppel defense. See United States v. Garan, 12 F.3d 858, 860-61 (9th Cir.1993); SCE Co. v. Pub. Utils. Comm'n, 85 Cal.App.4th 1086, 1110, 102 Cal.Rptr.2d 684, 701 (2000); Jovine v. FHP, Inc., 64 Cal.App.4th 1506, 1528, 76 Cal.Rptr.2d 322, 338 (1998).

Statements about the facts on the issues we are remanding for further proceedings are based on the summary judgment record. They are not meant to establish those facts as law of the case.

However, we agree with the district court that Ziarati and RTI have not presented clear and convincing evidence of waiver. See Jovine, 64 Cal.App.4th at 1527, 76 Cal.Rptr.2d at 338. Nor have they presented evidence of the mutual intent required for a modification or novation. See Wade v. Diamond A Cattle Co., 44 Cal.App.3d 453, 457, 118 Cal.Rptr. 695, 697 (1975); see also Howard v. County of Amador, 220 Cal.App.3d 962, 977, 269 Cal.Rptr. 807, 817 (1990).

AFFIRMED as to the waiver, novation, and modification defenses, otherwise REVERSED and REMANDED for further proceedings. Ziarati and RTI shall recover their costs on appeal.


Summaries of

GE Medical Systems v. Ziarati

United States Court of Appeals, Ninth Circuit
Jul 9, 2002
44 F. App'x 90 (9th Cir. 2002)
Case details for

GE Medical Systems v. Ziarati

Case Details

Full title:GE MEDICAL SYSTEMS, a division of General Electric Company, a New York…

Court:United States Court of Appeals, Ninth Circuit

Date published: Jul 9, 2002

Citations

44 F. App'x 90 (9th Cir. 2002)